Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2005

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2005
Quarter2
Financial Year End31/12/2005
The figureshave not been audited

Attachments

pharma_klse.doc
410 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2005


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2005 
30/06/2004 
30/06/2005 
30/06/2004 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
242,784
178,644
470,656
369,949
2Profit/(loss) before tax
14,312
16,264
32,561
36,933
3Profit/(loss)
after tax and minority
interest
8,711
10,882
19,410
23,266
4Net profit/(loss) for
the period
8,711
10,882
19,410
23,266
5Basic earnings/(loss) per share (sen)
8.51
10.77
19.00
23.05
6Dividend per share (sen)
0.00
4.50
0.00
4.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.5100
2.6000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Directors do not recommend any payment of interim dividend for the current period ended 30 June 2005 (2004:interim tax exempt dividend of 4.5 sen per share).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced18 Aug 2005  
CategoryFinancial Results
Reference NoCC-050817-32070